{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:35:01Z","timestamp":1769690101963,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41584-025-01344-4","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:04:45Z","timestamp":1766160285000},"page":"84-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progress in mechanisms and therapy for fibromyalgia"],"prefix":"10.1038","volume":"22","author":[{"given":"Hance","family":"Clarke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-3175","authenticated-orcid":false,"given":"Mary-Ann","family":"Fitzcharles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/brainsci15020206","volume":"15","author":"K Findeisen","year":"2025","unstructured":"Findeisen, K., Guymer, E. & Littlejohn, G. Neuroinflammatory and Immunological Aspects of Fibromyalgia. Brain Sci. 15, 206 (2025).","journal-title":"Brain Sci."},{"key":"1344_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf307","author":"EM Kelleher","year":"2025","unstructured":"Kelleher, E. M. et al. Brain signatures of nociplastic pain: Fibromyalgia Index and descending modulation at population level. Brain https:\/\/doi.org\/10.1093\/brain\/awaf307 (2025).","journal-title":"Brain"},{"key":"1344_CR3","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.neuron.2025.03.032","volume":"113","author":"W Cai","year":"2025","unstructured":"Cai, W. et al. The gut microbiota promotes pain in fibromyalgia. Neuron 113, 2161\u20132175.e2113 (2025).","journal-title":"Neuron"},{"key":"1344_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.14262","volume":"8","author":"W Caumo","year":"2025","unstructured":"Caumo, W. et al. Home-based transcranial direct current stimulation vs placebo for fibromyalgia: a randomized clinical trial. JAMA Netw. Open 8, e2514262 (2025).","journal-title":"JAMA Netw. Open"},{"key":"1344_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s40263-025-01183-7","volume":"39","author":"KD Bruun","year":"2025","unstructured":"Bruun, K. D. et al. Effect of naltrexone on spinal and supraspinal pain mechanisms and functional capacity in women with fibromyalgia: exploratory outcomes from the randomized placebo-controlled FINAL trial. CNS Drugs 39, 685\u2013692 (2025).","journal-title":"CNS Drugs"},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1097\/j.pain.0000000000001640","volume":"160","author":"A Minerbi","year":"2019","unstructured":"Minerbi, A. et al. Altered microbiome composition in individuals with fibromyalgia. Pain 160, 2589\u20132602 (2019).","journal-title":"Pain"},{"key":"1344_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03445-7","volume":"23","author":"R Moshfeghinia","year":"2023","unstructured":"Moshfeghinia, R. et al. The effects of transcranial direct-current stimulation (tDCS) on pain intensity of patients with fibromyalgia: a systematic review and meta-analysis. BMC Neurol. 23, 395 (2023).","journal-title":"BMC Neurol."},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neurom.2022.10.044","volume":"26","author":"PEP Teixeira","year":"2023","unstructured":"Teixeira, P. E. P. et al. The analgesic effect of transcranial direct current stimulation in fibromyalgia: a systematic review, meta-analysis, and meta-regression of potential influencers of clinical effect. Neuromodulation 26, 715\u2013727 (2023).","journal-title":"Neuromodulation"},{"key":"1344_CR9","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/S2665-9913(23)00278-3","volume":"6","author":"K Due Bruun","year":"2024","unstructured":"Due Bruun, K. et al. Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial. Lancet Rheumatol. 6, e31\u2013e39 (2024).","journal-title":"Lancet Rheumatol."},{"key":"1344_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/14737175.2025.2516097","volume":"25","author":"DL Goldenberg","year":"2025","unstructured":"Goldenberg, D. L. The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis\/chronic fatigue syndrome. Expert Rev. Neurother. 25, 973\u2013989 (2025).","journal-title":"Expert Rev. Neurother."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01344-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01344-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01344-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T01:02:35Z","timestamp":1769648555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01344-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1038\/s41584-025-01344-4","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"19 December 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.C. is the president of the Canadian Pain Society. M.-A.F. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}